Iovance Biotherapeutics Inc. buy Robert W. Baird
Start price
28.02.25
/
50%
€3.77
Target price
28.02.26
€19.21
Performance (%)
-45.25%
Price
04.02.26
€2.06
Summary
This prediction is currently active. The BUY prediction by Robert_W__Baird for Iovance Biotherapeutics Inc. is performing very badly with a performance of -45.25%. This prediction currently runs until 28.02.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | -10.557% | -10.557% |
| iShares Core DAX® | -1.020% | 0.271% |
| iShares Nasdaq 100 | -3.122% | -1.929% |
| iShares Nikkei 225® | 0.649% | 6.582% |
| iShares S&P 500 | -0.142% | -0.295% |
Comments by Robert_W__Baird for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its price target lowered by analysts at Robert W. Baird from $24.00 to $20.00. They now have an "outperform" rating on the stock.
Ratings data for IOVA provided by MarketBeat